HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
m Updated the table |
m Updated table |
||
| Line 1,916: | Line 1,916: | ||
|[[HAEM5:Leukaemic non-nodal mantle cell lymphoma|Leukaemic non-nodal mantle cell lymphoma]] | |[[HAEM5:Leukaemic non-nodal mantle cell lymphoma|Leukaemic non-nodal mantle cell lymphoma]] | ||
|Disease | |Disease | ||
| | |Pending | ||
| | | | ||
| | | | ||
| Line 1,925: | Line 1,925: | ||
| | | | ||
|NEW (No Prior) | |NEW (No Prior) | ||
| | |Farhan Sami, MD and Shivani Golem, PhD, FACMG | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|NEW (No Prior) | |NEW (No Prior) | ||
| Line 1,948: | Line 1,948: | ||
|[[HAEM5:Transformations of indolent B-cell lymphomas|Transformations of indolent B-cell lymphomas]] | |[[HAEM5:Transformations of indolent B-cell lymphomas|Transformations of indolent B-cell lymphomas]] | ||
|Disease | |Disease | ||
| | |Pending | ||
| | | | ||
| | | | ||
| Line 1,957: | Line 1,957: | ||
|Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation | |Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation | ||
|NEW (No Prior) | |NEW (No Prior) | ||
| | |Farhan Sami, MD and Shivani Golem, PhD, FACMG | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|NEW (No Prior) | |NEW (No Prior) | ||